The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.
The US Food and Drug Administration has granted de novo authorization to Paige.AI.’s Paige Prostate medical software to aid pathologists in finding prostate cancer. According to the agency, clinical data shows it significantly improved the detection of cancerous cells that otherwise would have gone unnoticed.
Paige, spun off from New York’s Memorial Sloan Kettering Cancer Center, develops artificial intelligence medical software to analyze diagnostic imaging...
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.
